Stimwave Receives FDA Approval for High Frequency IDE Utilizing the World’s First and Only Eight-Electrode, Multi-Programmable Wireless Miniature Injectable Stimulator

MIAMI--(BUSINESS WIRE)--Stimwave receives FDA approval to launch clinical trial utilizing the only wireless miniature eight electrode, multi-programmable neurostimulator device for the relief of chronic back and leg pain.